These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22115130)

  • 1. [Non-registered medicinal products: a renewal].
    Astier A
    Ann Pharm Fr; 2011 Nov; 69(6):283-5. PubMed ID: 22115130
    [No Abstract]   [Full Text] [Related]  

  • 2. Society of Hospital Pharmacists of Australia: are you at risk?
    Aust Hosp; 1981 Jul; (54):4-5. PubMed ID: 10254354
    [No Abstract]   [Full Text] [Related]  

  • 3. Health care and hospital pharmacy in Denmark.
    Nedergaard M
    Am J Hosp Pharm; 1977 Jun; 34(6):595-600. PubMed ID: 879180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current challenges in European oncology pharmacy practice.
    Hoppe-Tichy T
    J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and operation of an oncology satellite pharmacy.
    Eddlemon JK; Hayman JN; Breland BD
    Am J Hosp Pharm; 1984 Oct; 41(10):2045-8. PubMed ID: 6496493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on long-term, not short-term, effects of antineoplastic drug handling are needed.
    Slimowitz R; Mitrik LJ
    Am J Hosp Pharm; 1993 Sep; 50(9):1862-3. PubMed ID: 8135230
    [No Abstract]   [Full Text] [Related]  

  • 8. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineoplastic admixture service in a tertiary-care hospital.
    Friedman TS; Triboletti M; Sandusky RM; Katz S
    Am J Hosp Pharm; 1984 Oct; 41(10):2037-44. PubMed ID: 6496492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for the safe handling of injectable antineoplastic drug products.
    Zimmerman PF; Larsen RK; Barkley EW; Gallelli JF
    Am J Hosp Pharm; 1981 Nov; 38(11):1693-5. PubMed ID: 7304621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy program for improved handling of antineoplastic agents.
    Scott SA; Schrott DB; Loesch GA
    Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a clinically trained pharmacist in relation to future developments in health care.
    Riegelman S
    Pharm Weekbl; 1972 Oct; 107(40):625-36. PubMed ID: 4640611
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiopharmacists do more than prepare and dispense products.
    Wolf W; Kawada TK
    Am J Hosp Pharm; 1988 Sep; 45(9):1866-7. PubMed ID: 3228117
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unit dose radiopharmaceutical service as a component of total pharmacy practice.
    Barker LF; Evans WE
    Am J Hosp Pharm; 1976 Jan; 33(1):61-3. PubMed ID: 1266868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of pharmacy. Interview by Nancy Agresta.
    Durgin J
    Hosp Formul; 1980 Apr; 15(4):287-90, 293. PubMed ID: 10245911
    [No Abstract]   [Full Text] [Related]  

  • 18. Harvey A. K. Whitney lecture. Interdependence in pharmacy: risks, rewards, and responsibilities.
    Zilz DA
    Am J Hosp Pharm; 1990 Aug; 47(8):1759-65. PubMed ID: 2389781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy innovation: a public and private partnership.
    Mann JL; Tsallas G; Parks JS
    Can J Hosp Pharm; 1986 Aug; 39(4):107-8. PubMed ID: 10278470
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.